(19)
(11) EP 0 553 604 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
06.10.1993 Bulletin 1993/40

(43) Date of publication A2:
04.08.1993 Bulletin 1993/31

(21) Application number: 92850233.5

(22) Date of filing: 07.10.1992
(51) International Patent Classification (IPC)5A01N 37/44, A01N 39/00, A01N 35/04, A01N 43/42, A01N 43/40
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE

(30) Priority: 07.10.1991 SE 9102890

(71) Applicant: BAKER NORTON PHARMACEUTICALS, INC.
Miami, Florida 33178 (US)

(72) Inventor:
  • Evers, Hans
    S-151 59 Södertälje (SE)

(74) Representative: Karlsson, Leif Karl Gunnar et al
H.W. Barnieske Patentbyra AB P.O. Box 25
S-151 21 Södertälje
S-151 21 Södertälje (SE)


(56) References cited: : 
   
     
    Remarks:
    A request for correction of description, claims and abstract has been filed pursuant to Rule 88 EPC. A decision on the request will be taken during the proceedings before the Examining Division (Guidelines for Examination in the EPO, A-V, 2.2).
     


    (54) Insect repellant


    (57) An insect repellant composition for against mosquitoes or other insects that attack man and or warm-blooded animals contains up to 5 % by weight of a local anaesthetic selected from the group comprising alkyl p-aminobenzoate (I), arylamide of 2-aminoacetic acid (II), 2-aminoalkyl aryl ether (III), 2-aminoalkyl p-aminobensoate (IV) and mixtures thereof. Particularly preferred is lidocaine and a mixture of lidocaine and prilocaine.





    Search report